4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-15-004220
$NBYCIK 0001389545operating
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:44 PM ET
Size
9.1 KB
Accession
0001437749-15-004220
Insider Transaction Report
Form 4
Najafi Ramin
DirectorChief Executive OfficerOther
Transactions
- Purchase
Common Stock
2015-03-03$0.60/sh+166,666$100,000→ 3,391,666 total(indirect: By Trust) - Purchase
Warrant
2015-03-03$0.60/sh+166,666$100,000→ 291,665 total(indirect: By Trust)Exercise: $0.60From: 2015-09-06Exp: 2016-06-06→ Common Stock (166,666 underlying) - Purchase
Warrant
2015-03-03$0.65/sh+124,999$81,249→ 291,665 total(indirect: By Trust)Exercise: $0.65From: 2015-06-06Exp: 2020-06-06→ Common Stock (124,999 underlying)
Footnotes (1)
- [F1]Warrant to purchase common stock
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:44 PM ET
- Size
- 9.1 KB